David William Sides - 29 Jul 2021 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: Chief Operating Officer
Signature: /s/ Adam C. Vandervoort, attorney-in-fact
Issuer symbol: TDOC
Transactions as of: 29 Jul 2021
Net transactions value: -$527,966
Form type: 4
Filing time: 02 Aug 2021, 16:10:47 UTC
Next filing: 24 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+7,299	+102%		14,451	29 Jul 2021	Direct	F1
transaction	TDOC	Common Stock	Sale	$527,966	-3,420	-24%	$154.38^*	11,031	30 Jul 2021	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-7,299	-50%	$0.000000	7,299	29 Jul 2021	Common Stock	7,299		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2	On July 30, 2019, the reporting person was granted 21,897 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
F3	Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.